145 related articles for article (PubMed ID: 17005002)
21. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells.
Tanijiri T; Shimizu T; Uehira K; Yokoi T; Amuro H; Sugimoto H; Torii Y; Tajima K; Ito T; Amakawa R; Fukuhara S
J Leukoc Biol; 2007 Sep; 82(3):576-84. PubMed ID: 17545218
[TBL] [Abstract][Full Text] [Related]
23. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
25. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
26. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
Li L; Lao SH; Wu CY
Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
[TBL] [Abstract][Full Text] [Related]
27. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
[TBL] [Abstract][Full Text] [Related]
28. Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations.
Fuchizawa T; Adachi Y; Ito Y; Higashiyama H; Kanegane H; Futatani T; Kobayashi I; Kamachi Y; Sakamoto T; Tsuge I; Tanaka H; Banham AH; Ochs HD; Miyawaki T
Clin Immunol; 2007 Dec; 125(3):237-46. PubMed ID: 17916446
[TBL] [Abstract][Full Text] [Related]
29. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
Ebert LM; Tan BS; Browning J; Svobodova S; Russell SE; Kirkpatrick N; Gedye C; Moss D; Ng SP; MacGregor D; Davis ID; Cebon J; Chen W
Cancer Res; 2008 Apr; 68(8):3001-9. PubMed ID: 18413770
[TBL] [Abstract][Full Text] [Related]
30. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
[TBL] [Abstract][Full Text] [Related]
31. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
32. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
Liu Y; Amarnath S; Chen W
Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
[TBL] [Abstract][Full Text] [Related]
33. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
[TBL] [Abstract][Full Text] [Related]
34. The functional insufficiency of human CD4+CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation.
Lin YL; Shieh CC; Wang JY
Allergy; 2008 Jan; 63(1):67-74. PubMed ID: 18053016
[TBL] [Abstract][Full Text] [Related]
35. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
36. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.
Rensing-Ehl A; Gaus B; Bruckner-Tuderman L; Martin SF
Exp Dermatol; 2007 Jan; 16(1):13-21. PubMed ID: 17181632
[TBL] [Abstract][Full Text] [Related]
37. Kinetic assessment of general gene expression changes during human naive CD4+ T cell activation.
Hess K; Yang Y; Golech S; Sharov A; Becker KG; Weng NP
Int Immunol; 2004 Dec; 16(12):1711-21. PubMed ID: 15492022
[TBL] [Abstract][Full Text] [Related]
38. Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo.
Joly AL; Liu S; Dahlberg CI; Mailer RK; Westerberg LS; Andersson J
J Autoimmun; 2015 Sep; 63():23-30. PubMed ID: 26149776
[TBL] [Abstract][Full Text] [Related]
39. Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c.
Xue Q; Guo ZY; Li W; Wen WH; Meng YL; Jia LT; Wang J; Yao LB; Jin BQ; Wang T; Yang AG
Mol Immunol; 2011 Jan; 48(4):592-9. PubMed ID: 21112091
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning, expression and functional characterization of miniature swine CD86.
Choi I; Cho B; Kim SD; Park D; Kim JY; Park CG; Chung DH; Hwang WS; Lee JS; Ahn C
Mol Immunol; 2006 Feb; 43(5):480-6. PubMed ID: 16337491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
